Durvalumab vs Enalapril

Durvalumab vs Enalapril: Overview

This comparison examines the pharmacological differences between Durvalumab and Enalapril.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Enalapril: Prodrug converted to enalaprilat; inhibits ACE preventing angiotensin I to II conversion.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Enalapril — 11 hours.

Chemical Properties

Molecular Formula: Enalapril — C20H28N2O5.

Molecular Weight: Enalapril — 376.4470 g/mol.

Type: Durvalumab — Antibody; Enalapril — Small molecule.